These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. HPV in situ hybridization: impact of different protocols on the detection of integrated HPV. Hopman AH, Kamps MA, Smedts F, Speel EJ, Herrington CS, Ramaekers FC. Int J Cancer; 2005 Jun 20; 115(3):419-28. PubMed ID: 15688369 [Abstract] [Full Text] [Related]
4. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade. Hudelist G, Manavi M, Pischinger KI, Watkins-Riedel T, Singer CF, Kubista E, Czerwenka KF. Gynecol Oncol; 2004 Mar 20; 92(3):873-80. PubMed ID: 14984955 [Abstract] [Full Text] [Related]
8. DNA aneuploidy and integration of human papillomavirus type 16 e6/e7 oncogenes in intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri. Melsheimer P, Vinokurova S, Wentzensen N, Bastert G, von Knebel Doeberitz M. Clin Cancer Res; 2004 May 01; 10(9):3059-63. PubMed ID: 15131043 [Abstract] [Full Text] [Related]
9. Reduction in the copy number and expression level of the recurrent human papillomavirus integration gene fragile histidine triad (FHIT) predicts the transition of cervical lesions. Wang L, Shen H, Feng B, Zhu D, Yu L, Tian X, Ren C, Gao C, Li X, Ma D, Hu Z, Wang H. PLoS One; 2017 May 01; 12(4):e0175520. PubMed ID: 28414756 [Abstract] [Full Text] [Related]
11. Monoclonal expansion with integration of high-risk type human papillomaviruses is an initial step for cervical carcinogenesis: association of clonal status and human papillomavirus infection with clinical outcome in cervical intraepithelial neoplasia. Ueda Y, Enomoto T, Miyatake T, Ozaki K, Yoshizaki T, Kanao H, Ueno Y, Nakashima R, Shroyer KR, Murata Y. Lab Invest; 2003 Oct 01; 83(10):1517-27. PubMed ID: 14563953 [Abstract] [Full Text] [Related]
15. The physical state of HPV16 infection and its clinical significance in cancer precursor lesion and cervical carcinoma. Li W, Wang W, Si M, Han L, Gao Q, Luo A, Li Y, Lu Y, Wang S, Ma D. J Cancer Res Clin Oncol; 2008 Dec 01; 134(12):1355-61. PubMed ID: 18478264 [Abstract] [Full Text] [Related]
16. Evaluation of a commercialized in situ hybridization assay for detecting human papillomavirus DNA in tissue specimens from patients with cervical intraepithelial neoplasia and cervical carcinoma. Guo M, Gong Y, Deavers M, Silva EG, Jan YJ, Cogdell DE, Luthra R, Lin E, Lai HC, Zhang W, Sneige N. J Clin Microbiol; 2008 Jan 01; 46(1):274-80. PubMed ID: 17977987 [Abstract] [Full Text] [Related]
18. Genomic amplification of the human telomerase gene (hTERC) associated with human papillomavirus is related to the progression of uterine cervical dysplasia to invasive cancer. Liu H, Liu S, Wang H, Xie X, Chen X, Zhang X, Zhang Y. Diagn Pathol; 2012 Oct 30; 7():147. PubMed ID: 23107094 [Abstract] [Full Text] [Related]
19. HPV 16 in multiple neoplastic lesions in women with CIN III. Hennig EM, Di Lonardo A, Venuti A, Holm R, Marcante ML, Nesland JM. J Exp Clin Cancer Res; 1999 Sep 30; 18(3):369-77. PubMed ID: 10606184 [Abstract] [Full Text] [Related]